ZA200301579B - Plant polynucleotides encoding prenyl proteases. - Google Patents

Plant polynucleotides encoding prenyl proteases. Download PDF

Info

Publication number: ZA200301579B
Authority: ZA; South Africa
Prior art keywords: nucleic acid; plant; polynucleotide; seq; polypeptide
Prior art date: 2000-08-25

Application number

ZA200301579A

Other languages

English (en)

Inventor

Heiko Heartel

Volker Mittendorf

Stefan Henkes

Costa E Da

Oswaldo Silva

Original Assignee

Basf Plant Science Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-25

Filing date

2001-08-27

Publication date

2004-06-21

2001-08-27 Application filed by Basf Plant Science Gmbh filed Critical Basf Plant Science Gmbh

2004-06-21 Publication of ZA200301579B publication Critical patent/ZA200301579B/en

Links

102000040430 polynucleotide Human genes 0.000 title claims abstract description 366
108091033319 polynucleotide Proteins 0.000 title claims abstract description 366
239000002157 polynucleotide Substances 0.000 title claims abstract description 366
108091005804 Peptidases Proteins 0.000 title claims abstract description 54
125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 title claims abstract description 51
239000004365 Protease Substances 0.000 title claims abstract description 37
102000035195 Peptidases Human genes 0.000 title description 38
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 419
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 404
229920001184 polypeptide Polymers 0.000 claims abstract description 398
238000000034 method Methods 0.000 claims abstract description 251
239000013598 vector Substances 0.000 claims abstract description 29
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract 16
241000196324 Embryophyta Species 0.000 claims description 322
108090000623 proteins and genes Proteins 0.000 claims description 290
150000007523 nucleic acids Chemical class 0.000 claims description 136
102000004169 proteins and genes Human genes 0.000 claims description 134
102000039446 nucleic acids Human genes 0.000 claims description 130
108020004707 nucleic acids Proteins 0.000 claims description 130
230000014509 gene expression Effects 0.000 claims description 92
125000003729 nucleotide group Chemical group 0.000 claims description 77
239000002773 nucleotide Substances 0.000 claims description 76
230000001965 increasing effect Effects 0.000 claims description 58
230000006870 function Effects 0.000 claims description 55
230000035882 stress Effects 0.000 claims description 39
230000009261 transgenic effect Effects 0.000 claims description 37
108091028043 Nucleic acid sequence Proteins 0.000 claims description 24
230000013498 protein farnesylation Effects 0.000 claims description 24
235000010469 Glycine max Nutrition 0.000 claims description 15
244000068988 Glycine max Species 0.000 claims description 15
230000000295 complement effect Effects 0.000 claims description 15
230000006353 environmental stress Effects 0.000 claims description 13
240000008042 Zea mays Species 0.000 claims description 12
235000004977 Brassica sinapistrum Nutrition 0.000 claims description 11
235000002017 Zea mays subsp mays Nutrition 0.000 claims description 10
230000001105 regulatory effect Effects 0.000 claims description 10
230000003247 decreasing effect Effects 0.000 claims description 9
239000013604 expression vector Substances 0.000 claims description 9
230000001131 transforming effect Effects 0.000 claims description 9
240000002791 Brassica napus Species 0.000 claims description 8
235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 6
240000003768 Solanum lycopersicum Species 0.000 claims description 6
239000002253 acid Substances 0.000 claims description 6
241001233957 eudicotyledons Species 0.000 claims description 6
229920000742 Cotton Polymers 0.000 claims description 5
241000219146 Gossypium Species 0.000 claims description 5
244000061176 Nicotiana tabacum Species 0.000 claims description 5
235000002637 Nicotiana tabacum Nutrition 0.000 claims description 5
235000007164 Oryza sativa Nutrition 0.000 claims description 5
235000009566 rice Nutrition 0.000 claims description 5
238000009395 breeding Methods 0.000 claims description 4
230000001488 breeding effect Effects 0.000 claims description 4
230000007613 environmental effect Effects 0.000 claims description 4
235000017060 Arachis glabrata Nutrition 0.000 claims 4
244000105624 Arachis hypogaea Species 0.000 claims 4
235000010777 Arachis hypogaea Nutrition 0.000 claims 4
235000018262 Arachis monticola Nutrition 0.000 claims 4
235000007319 Avena orientalis Nutrition 0.000 claims 4
241000209763 Avena sativa Species 0.000 claims 4
235000007558 Avena sp Nutrition 0.000 claims 4
235000014698 Brassica juncea var multisecta Nutrition 0.000 claims 4
235000006008 Brassica napus var napus Nutrition 0.000 claims 4
235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims 4
244000188595 Brassica sinapistrum Species 0.000 claims 4
235000002566 Capsicum Nutrition 0.000 claims 4
244000060011 Cocos nucifera Species 0.000 claims 4
235000013162 Cocos nucifera Nutrition 0.000 claims 4
240000007154 Coffea arabica Species 0.000 claims 4
241000380130 Ehrharta erecta Species 0.000 claims 4
235000001950 Elaeis guineensis Nutrition 0.000 claims 4
244000127993 Elaeis melanococca Species 0.000 claims 4
244000020551 Helianthus annuus Species 0.000 claims 4
235000003222 Helianthus annuus Nutrition 0.000 claims 4
240000005979 Hordeum vulgare Species 0.000 claims 4
235000007340 Hordeum vulgare Nutrition 0.000 claims 4
241000209510 Liliopsida Species 0.000 claims 4
240000003183 Manihot esculenta Species 0.000 claims 4
241000219823 Medicago Species 0.000 claims 4
235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims 4
240000007594 Oryza sativa Species 0.000 claims 4
239000006002 Pepper Substances 0.000 claims 4
235000016761 Piper aduncum Nutrition 0.000 claims 4
240000003889 Piper guineense Species 0.000 claims 4
235000017804 Piper guineense Nutrition 0.000 claims 4
235000008184 Piper nigrum Nutrition 0.000 claims 4
240000004713 Pisum sativum Species 0.000 claims 4
235000010582 Pisum sativum Nutrition 0.000 claims 4
241000124033 Salix Species 0.000 claims 4
241000209056 Secale Species 0.000 claims 4
235000007238 Secale cereale Nutrition 0.000 claims 4
244000061458 Solanum melongena Species 0.000 claims 4
235000002597 Solanum melongena Nutrition 0.000 claims 4
244000061456 Solanum tuberosum Species 0.000 claims 4
235000002595 Solanum tuberosum Nutrition 0.000 claims 4
235000012308 Tagetes Nutrition 0.000 claims 4
241000736851 Tagetes Species 0.000 claims 4
244000269722 Thea sinensis Species 0.000 claims 4
244000299461 Theobroma cacao Species 0.000 claims 4
235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 claims 4
235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 claims 4
235000019714 Triticale Nutrition 0.000 claims 4
241000209140 Triticum Species 0.000 claims 4
235000021307 Triticum Nutrition 0.000 claims 4
241000219873 Vicia Species 0.000 claims 4
235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims 4
235000001046 cacaotero Nutrition 0.000 claims 4
235000016213 coffee Nutrition 0.000 claims 4
235000013353 coffee beverage Nutrition 0.000 claims 4
239000004459 forage Substances 0.000 claims 4
235000009973 maize Nutrition 0.000 claims 4
235000005739 manihot Nutrition 0.000 claims 4
235000020232 peanut Nutrition 0.000 claims 4
235000013616 tea Nutrition 0.000 claims 4
241000228158 x Triticosecale Species 0.000 claims 4
230000006342 environmental stress response Effects 0.000 claims 3
230000009452 underexpressoin Effects 0.000 claims 1
239000012634 fragment Substances 0.000 abstract description 86
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 26
201000010099 disease Diseases 0.000 abstract description 15
238000010188 recombinant method Methods 0.000 abstract description 6
230000002265 prevention Effects 0.000 abstract description 4
235000018102 proteins Nutrition 0.000 description 125
210000004027 cell Anatomy 0.000 description 104
235000001014 amino acid Nutrition 0.000 description 73
125000003275 alpha amino acid group Chemical group 0.000 description 57
229940024606 amino acid Drugs 0.000 description 57
108020004414 DNA Proteins 0.000 description 56
210000001519 tissue Anatomy 0.000 description 53
150000001413 amino acids Chemical class 0.000 description 52
241000282414 Homo sapiens Species 0.000 description 50
239000000523 sample Substances 0.000 description 47
235000002639 sodium chloride Nutrition 0.000 description 44
150000003839 salts Chemical class 0.000 description 41
230000000694 effects Effects 0.000 description 38
230000008635 plant growth Effects 0.000 description 38
239000002299 complementary DNA Substances 0.000 description 36
230000006126 farnesylation Effects 0.000 description 32
-1 C-5 propyne analogues Chemical class 0.000 description 31
238000012217 deletion Methods 0.000 description 30
230000037430 deletion Effects 0.000 description 30
108091032973 (ribonucleotides)n+m Proteins 0.000 description 29
230000004071 biological effect Effects 0.000 description 29
230000008827 biological function Effects 0.000 description 28
230000000692 anti-sense effect Effects 0.000 description 27
102000004190 Enzymes Human genes 0.000 description 25
108090000790 Enzymes Proteins 0.000 description 25
239000005557 antagonist Substances 0.000 description 25
229940088598 enzyme Drugs 0.000 description 25
229920000642 polymer Polymers 0.000 description 25
241000219194 Arabidopsis Species 0.000 description 24
239000002502 liposome Substances 0.000 description 24
238000006467 substitution reaction Methods 0.000 description 23
240000004808 Saccharomyces cerevisiae Species 0.000 description 21
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 21
230000027455 binding Effects 0.000 description 21
210000000349 chromosome Anatomy 0.000 description 21
150000001875 compounds Chemical class 0.000 description 21
230000024346 drought recovery Effects 0.000 description 21
230000002068 genetic effect Effects 0.000 description 21
230000001939 inductive effect Effects 0.000 description 21
241000192700 Cyanobacteria Species 0.000 description 20
238000003556 assay Methods 0.000 description 20
238000003753 real-time PCR Methods 0.000 description 20
230000002018 overexpression Effects 0.000 description 19
108060003951 Immunoglobulin Proteins 0.000 description 18
230000036579 abiotic stress Effects 0.000 description 18
102000018358 immunoglobulin Human genes 0.000 description 18
235000019833 protease Nutrition 0.000 description 18
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
108010006519 Molecular Chaperones Proteins 0.000 description 17
230000001580 bacterial effect Effects 0.000 description 17
230000004790 biotic stress Effects 0.000 description 17
108020004999 messenger RNA Proteins 0.000 description 17
239000000556 agonist Substances 0.000 description 16
102000037865 fusion proteins Human genes 0.000 description 16
108020001507 fusion proteins Proteins 0.000 description 16
230000015784 hyperosmotic salinity response Effects 0.000 description 16
239000000463 material Substances 0.000 description 16
230000035772 mutation Effects 0.000 description 16
241000192584 Synechocystis Species 0.000 description 15
150000001720 carbohydrates Chemical class 0.000 description 15
230000012010 growth Effects 0.000 description 15
238000003752 polymerase chain reaction Methods 0.000 description 15
238000002360 preparation method Methods 0.000 description 15
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 14
108010076504 Protein Sorting Signals Proteins 0.000 description 14
230000015572 biosynthetic process Effects 0.000 description 14
210000004899 c-terminal region Anatomy 0.000 description 14
238000009396 hybridization Methods 0.000 description 14
238000000746 purification Methods 0.000 description 14
239000000126 substance Substances 0.000 description 14
108091026890 Coding region Proteins 0.000 description 13
108700026244 Open Reading Frames Proteins 0.000 description 13
108091093037 Peptide nucleic acid Proteins 0.000 description 13
238000003776 cleavage reaction Methods 0.000 description 13
239000012530 fluid Substances 0.000 description 13
239000004009 herbicide Substances 0.000 description 13
210000004408 hybridoma Anatomy 0.000 description 13
239000000203 mixture Substances 0.000 description 13
230000037361 pathway Effects 0.000 description 13
229920001223 polyethylene glycol Polymers 0.000 description 13
235000019419 proteases Nutrition 0.000 description 13
230000007017 scission Effects 0.000 description 13
125000000539 amino acid group Chemical group 0.000 description 12
239000012472 biological sample Substances 0.000 description 12
230000004927 fusion Effects 0.000 description 12
238000004519 manufacturing process Methods 0.000 description 12
239000013615 primer Substances 0.000 description 12
230000008569 process Effects 0.000 description 12
241001465754 Metazoa Species 0.000 description 11
238000007792 addition Methods 0.000 description 11
238000004458 analytical method Methods 0.000 description 11
239000000427 antigen Substances 0.000 description 11
238000000338 in vitro Methods 0.000 description 11
230000009466 transformation Effects 0.000 description 11
JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 10
108010007508 Farnesyltranstransferase Proteins 0.000 description 10
108010016634 Seed Storage Proteins Proteins 0.000 description 10
108091007433 antigens Proteins 0.000 description 10
102000036639 antigens Human genes 0.000 description 10
238000010367 cloning Methods 0.000 description 10
208000035475 disorder Diseases 0.000 description 10
238000001415 gene therapy Methods 0.000 description 10
241000894007 species Species 0.000 description 10
108020004705 Codon Proteins 0.000 description 9
241000588724 Escherichia coli Species 0.000 description 9
102000007317 Farnesyltranstransferase Human genes 0.000 description 9
108091034117 Oligonucleotide Proteins 0.000 description 9
125000002091 cationic group Chemical group 0.000 description 9
230000001413 cellular effect Effects 0.000 description 9
239000003153 chemical reaction reagent Substances 0.000 description 9
230000007423 decrease Effects 0.000 description 9
239000003921 oil Substances 0.000 description 9
238000003786 synthesis reaction Methods 0.000 description 9
230000014616 translation Effects 0.000 description 9
230000003612 virological effect Effects 0.000 description 9
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 8
230000004075 alteration Effects 0.000 description 8
210000003763 chloroplast Anatomy 0.000 description 8
230000002950 deficient Effects 0.000 description 8
230000028993 immune response Effects 0.000 description 8
229940124452 immunizing agent Drugs 0.000 description 8
239000003550 marker Substances 0.000 description 8
230000008121 plant development Effects 0.000 description 8
239000003053 toxin Substances 0.000 description 8
231100000765 toxin Toxicity 0.000 description 8
108700012359 toxins Proteins 0.000 description 8
238000013519 translation Methods 0.000 description 8
238000011282 treatment Methods 0.000 description 8
102000005431 Molecular Chaperones Human genes 0.000 description 7
241000699666 Mus <mouse, genus> Species 0.000 description 7
235000014633 carbohydrates Nutrition 0.000 description 7
230000032823 cell division Effects 0.000 description 7
230000004663 cell proliferation Effects 0.000 description 7
230000008859 change Effects 0.000 description 7
230000002163 immunogen Effects 0.000 description 7
238000001727 in vivo Methods 0.000 description 7
239000003446 ligand Substances 0.000 description 7
230000000670 limiting effect Effects 0.000 description 7
239000011159 matrix material Substances 0.000 description 7
230000004048 modification Effects 0.000 description 7
238000012986 modification Methods 0.000 description 7
239000002243 precursor Substances 0.000 description 7
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 7
238000007670 refining Methods 0.000 description 7
238000011160 research Methods 0.000 description 7
238000012163 sequencing technique Methods 0.000 description 7
238000003860 storage Methods 0.000 description 7
SNKAWJBJQDLSFF-NVKMUCNASA-N 1,2-dioleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC SNKAWJBJQDLSFF-NVKMUCNASA-N 0.000 description 6
241000219195 Arabidopsis thaliana Species 0.000 description 6
241000219308 Atriplex nummularia Species 0.000 description 6
SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 6
108090001090 Lectins Proteins 0.000 description 6
102000004856 Lectins Human genes 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
108091023040 Transcription factor Proteins 0.000 description 6
102000040945 Transcription factor Human genes 0.000 description 6
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 6
DSNRWDQKZIEDDB-GCMPNPAFSA-N [(2r)-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-[(z)-octadec-9-enoyl]oxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C/CCCCCCCC DSNRWDQKZIEDDB-GCMPNPAFSA-N 0.000 description 6
239000002671 adjuvant Substances 0.000 description 6
230000000890 antigenic effect Effects 0.000 description 6
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 6
230000008901 benefit Effects 0.000 description 6
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 6
210000001124 body fluid Anatomy 0.000 description 6
230000022131 cell cycle Effects 0.000 description 6
230000002759 chromosomal effect Effects 0.000 description 6
235000005822 corn Nutrition 0.000 description 6
238000011161 development Methods 0.000 description 6
230000018109 developmental process Effects 0.000 description 6
238000003384 imaging method Methods 0.000 description 6
208000015181 infectious disease Diseases 0.000 description 6
238000002347 injection Methods 0.000 description 6
239000007924 injection Substances 0.000 description 6
239000002523 lectin Substances 0.000 description 6
150000002632 lipids Chemical class 0.000 description 6
230000004060 metabolic process Effects 0.000 description 6
230000035407 negative regulation of cell proliferation Effects 0.000 description 6
108020003175 receptors Proteins 0.000 description 6
102000005962 receptors Human genes 0.000 description 6
235000000346 sugar Nutrition 0.000 description 6
230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 6
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
241000124008 Mammalia Species 0.000 description 5
241001529936 Murinae Species 0.000 description 5
206010028980 Neoplasm Diseases 0.000 description 5
206010035226 Plasma cell myeloma Diseases 0.000 description 5
238000011529 RT qPCR Methods 0.000 description 5
230000009471 action Effects 0.000 description 5
239000010839 body fluid Substances 0.000 description 5
239000003795 chemical substances by application Substances 0.000 description 5
238000004590 computer program Methods 0.000 description 5
FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 5
210000002257 embryonic structure Anatomy 0.000 description 5
238000010195 expression analysis Methods 0.000 description 5
238000009472 formulation Methods 0.000 description 5
125000000524 functional group Chemical group 0.000 description 5
239000000499 gel Substances 0.000 description 5
239000001963 growth medium Substances 0.000 description 5
229920001477 hydrophilic polymer Polymers 0.000 description 5
238000013507 mapping Methods 0.000 description 5
229930182817 methionine Natural products 0.000 description 5
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 5
238000002493 microarray Methods 0.000 description 5
201000000050 myeloid neoplasm Diseases 0.000 description 5
235000019198 oils Nutrition 0.000 description 5
239000002987 primer (paints) Substances 0.000 description 5
239000000047 product Substances 0.000 description 5
230000002829 reductive effect Effects 0.000 description 5
238000007894 restriction fragment length polymorphism technique Methods 0.000 description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
KWVJHCQQUFDPLU-YEUCEMRASA-N 2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC KWVJHCQQUFDPLU-YEUCEMRASA-N 0.000 description 4
241000894006 Bacteria Species 0.000 description 4
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
108020004635 Complementary DNA Proteins 0.000 description 4
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
108010042283 HSP40 Heat-Shock Proteins Proteins 0.000 description 4
102000018251 Hypoxanthine Phosphoribosyltransferase Human genes 0.000 description 4
108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 4
108010021625 Immunoglobulin Fragments Proteins 0.000 description 4
102000008394 Immunoglobulin Fragments Human genes 0.000 description 4
241000195887 Physcomitrella patens Species 0.000 description 4
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
229930006000 Sucrose Natural products 0.000 description 4
239000003490 Thiodipropionic acid Substances 0.000 description 4
241000700605 Viruses Species 0.000 description 4
HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 4
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
238000004422 calculation algorithm Methods 0.000 description 4
229910052799 carbon Inorganic materials 0.000 description 4
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
239000003184 complementary RNA Substances 0.000 description 4
238000012937 correction Methods 0.000 description 4
238000002405 diagnostic procedure Methods 0.000 description 4
210000003527 eukaryotic cell Anatomy 0.000 description 4
230000009395 genetic defect Effects 0.000 description 4
238000002873 global sequence alignment Methods 0.000 description 4
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 4
229940072221 immunoglobulins Drugs 0.000 description 4
230000001976 improved effect Effects 0.000 description 4
230000001404 mediated effect Effects 0.000 description 4
239000002609 medium Substances 0.000 description 4
239000012528 membrane Substances 0.000 description 4
230000000243 photosynthetic effect Effects 0.000 description 4
210000002706 plastid Anatomy 0.000 description 4
229920002451 polyvinyl alcohol Polymers 0.000 description 4
238000003127 radioimmunoassay Methods 0.000 description 4
239000005720 sucrose Substances 0.000 description 4
150000008163 sugars Chemical class 0.000 description 4
238000013518 transcription Methods 0.000 description 4
230000035897 transcription Effects 0.000 description 4
238000001890 transfection Methods 0.000 description 4
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
LDGWQMRUWMSZIU-LQDDAWAPSA-M 2,3-bis[(z)-octadec-9-enoxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCCOCC(C[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC LDGWQMRUWMSZIU-LQDDAWAPSA-M 0.000 description 3
108010088751 Albumins Proteins 0.000 description 3
102000009027 Albumins Human genes 0.000 description 3
108020005544 Antisense RNA Proteins 0.000 description 3
102000000584 Calmodulin Human genes 0.000 description 3
108010041952 Calmodulin Proteins 0.000 description 3
108090000994 Catalytic RNA Proteins 0.000 description 3
102000053642 Catalytic RNA Human genes 0.000 description 3
108010047041 Complementarity Determining Regions Proteins 0.000 description 3
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
108010066133 D-octopine dehydrogenase Proteins 0.000 description 3
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 3
229930091371 Fructose Natural products 0.000 description 3
239000005715 Fructose Substances 0.000 description 3
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 3
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
241000238631 Hexapoda Species 0.000 description 3
102000013463 Immunoglobulin Light Chains Human genes 0.000 description 3
108010065825 Immunoglobulin Light Chains Proteins 0.000 description 3
108091092195 Intron Proteins 0.000 description 3
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
229930195725 Mannitol Natural products 0.000 description 3
238000005481 NMR spectroscopy Methods 0.000 description 3
239000003216 Oxystearin Substances 0.000 description 3
108091000080 Phosphotransferase Proteins 0.000 description 3
239000004952 Polyamide Substances 0.000 description 3
239000002202 Polyethylene glycol Substances 0.000 description 3
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 3
241000283984 Rodentia Species 0.000 description 3
108091081024 Start codon Proteins 0.000 description 3
150000007513 acids Chemical class 0.000 description 3
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 3
QWCKQJZIFLGMSD-UHFFFAOYSA-N alpha-aminobutyric acid Chemical compound CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 3
125000000129 anionic group Chemical group 0.000 description 3
PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 3
238000012742 biochemical analysis Methods 0.000 description 3
201000011510 cancer Diseases 0.000 description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
238000004587 chromatography analysis Methods 0.000 description 3
230000007123 defense Effects 0.000 description 3
238000003745 diagnosis Methods 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
230000002255 enzymatic effect Effects 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
230000002209 hydrophobic effect Effects 0.000 description 3
210000000987 immune system Anatomy 0.000 description 3
230000003053 immunization Effects 0.000 description 3
238000002649 immunization Methods 0.000 description 3
238000001114 immunoprecipitation Methods 0.000 description 3
239000003112 inhibitor Substances 0.000 description 3
230000002401 inhibitory effect Effects 0.000 description 3
238000003780 insertion Methods 0.000 description 3
230000037431 insertion Effects 0.000 description 3
229930027917 kanamycin Natural products 0.000 description 3
229960000318 kanamycin Drugs 0.000 description 3
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
229930182823 kanamycin A Natural products 0.000 description 3
210000004698 lymphocyte Anatomy 0.000 description 3
210000004962 mammalian cell Anatomy 0.000 description 3
239000000594 mannitol Substances 0.000 description 3
235000010355 mannitol Nutrition 0.000 description 3
230000007935 neutral effect Effects 0.000 description 3
239000002245 particle Substances 0.000 description 3
102000020233 phosphotransferase Human genes 0.000 description 3
239000013612 plasmid Substances 0.000 description 3
229920002647 polyamide Polymers 0.000 description 3
102000054765 polymorphisms of proteins Human genes 0.000 description 3
239000004297 potassium metabisulphite Substances 0.000 description 3
238000012545 processing Methods 0.000 description 3
230000004853 protein function Effects 0.000 description 3
239000004172 quinoline yellow Substances 0.000 description 3
230000009467 reduction Effects 0.000 description 3
230000010076 replication Effects 0.000 description 3
230000001177 retroviral effect Effects 0.000 description 3
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 3
108091092562 ribozyme Proteins 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
229910001415 sodium ion Inorganic materials 0.000 description 3
GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulphite Substances [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 3
239000004328 sodium tetraborate Substances 0.000 description 3
239000007787 solid Substances 0.000 description 3
239000000243 solution Substances 0.000 description 3
238000000527 sonication Methods 0.000 description 3
239000000600 sorbitol Substances 0.000 description 3
230000000087 stabilizing effect Effects 0.000 description 3
230000008685 targeting Effects 0.000 description 3
239000004149 tartrazine Substances 0.000 description 3
229930101283 tetracycline Natural products 0.000 description 3
239000002691 unilamellar liposome Substances 0.000 description 3
238000011144 upstream manufacturing Methods 0.000 description 3
239000011782 vitamin Substances 0.000 description 3
229940088594 vitamin Drugs 0.000 description 3
229930003231 vitamin Natural products 0.000 description 3
235000013343 vitamin Nutrition 0.000 description 3
HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical class CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 description 2
102100033400 4F2 cell-surface antigen heavy chain Human genes 0.000 description 2
LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
102000007469 Actins Human genes 0.000 description 2
108010085238 Actins Proteins 0.000 description 2
241000589155 Agrobacterium tumefaciens Species 0.000 description 2
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
108020004491 Antisense DNA Proteins 0.000 description 2
239000004475 Arginine Substances 0.000 description 2
206010003445 Ascites Diseases 0.000 description 2
125000001433 C-terminal amino-acid group Chemical group 0.000 description 2
101100230428 Caenorhabditis elegans hil-5 gene Proteins 0.000 description 2
229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
102000014914 Carrier Proteins Human genes 0.000 description 2
241000701489 Cauliflower mosaic virus Species 0.000 description 2
238000002883 ClustalW sequence alignment Methods 0.000 description 2
108091035707 Consensus sequence Proteins 0.000 description 2
241000701022 Cytomegalovirus Species 0.000 description 2
GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 2
RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
YTBSYETUWUMLBZ-QWWZWVQMSA-N D-threose Chemical compound OC[C@@H](O)[C@H](O)C=O YTBSYETUWUMLBZ-QWWZWVQMSA-N 0.000 description 2
229920002307 Dextran Polymers 0.000 description 2
241000206602 Eukaryota Species 0.000 description 2
108700024394 Exon Proteins 0.000 description 2
241000233866 Fungi Species 0.000 description 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
239000001922 Gum ghatti Substances 0.000 description 2
102000004447 HSP40 Heat-Shock Proteins Human genes 0.000 description 2
108010093488 His-His-His-His-His-His Proteins 0.000 description 2
241000282412 Homo Species 0.000 description 2
101000800023 Homo sapiens 4F2 cell-surface antigen heavy chain Proteins 0.000 description 2
108090000144 Human Proteins Proteins 0.000 description 2
102000003839 Human Proteins Human genes 0.000 description 2
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 2
102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 2
108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 2
102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 2
108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 2
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
102000004895 Lipoproteins Human genes 0.000 description 2
108090001030 Lipoproteins Proteins 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
108010052285 Membrane Proteins Proteins 0.000 description 2
102000018697 Membrane Proteins Human genes 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
241000244206 Nematoda Species 0.000 description 2
108010077850 Nuclear Localization Signals Proteins 0.000 description 2
239000004677 Nylon Substances 0.000 description 2
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
239000004698 Polyethylene Substances 0.000 description 2
239000004372 Polyvinyl alcohol Substances 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
108091028664 Ribonucleotide Proteins 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
239000004098 Tetracycline Substances 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
235000007244 Zea mays Nutrition 0.000 description 2
QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
230000021736 acetylation Effects 0.000 description 2
238000006640 acetylation reaction Methods 0.000 description 2
238000005917 acylation reaction Methods 0.000 description 2
238000001042 affinity chromatography Methods 0.000 description 2
238000001261 affinity purification Methods 0.000 description 2
230000002776 aggregation Effects 0.000 description 2
238000004220 aggregation Methods 0.000 description 2
235000010443 alginic acid Nutrition 0.000 description 2
229920000615 alginic acid Polymers 0.000 description 2
239000000783 alginic acid Substances 0.000 description 2
229960001126 alginic acid Drugs 0.000 description 2
150000004781 alginic acids Chemical class 0.000 description 2
230000029936 alkylation Effects 0.000 description 2
238000005804 alkylation reaction Methods 0.000 description 2
208000026935 allergic disease Diseases 0.000 description 2
230000000172 allergic effect Effects 0.000 description 2
HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 2
150000001412 amines Chemical class 0.000 description 2
230000003321 amplification Effects 0.000 description 2
230000003466 anti-cipated effect Effects 0.000 description 2
239000003816 antisense DNA Substances 0.000 description 2
238000013459 approach Methods 0.000 description 2
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
208000010668 atopic eczema Diseases 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
238000001574 biopsy Methods 0.000 description 2
229960002685 biotin Drugs 0.000 description 2
235000020958 biotin Nutrition 0.000 description 2
239000011616 biotin Substances 0.000 description 2
238000010804 cDNA synthesis Methods 0.000 description 2
239000011575 calcium Substances 0.000 description 2
239000001506 calcium phosphate Substances 0.000 description 2
229910000389 calcium phosphate Inorganic materials 0.000 description 2
235000011010 calcium phosphates Nutrition 0.000 description 2
239000001768 carboxy methyl cellulose Substances 0.000 description 2
235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
239000008112 carboxymethyl-cellulose Substances 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
235000012000 cholesterol Nutrition 0.000 description 2
238000004883 computer application Methods 0.000 description 2
230000021615 conjugation Effects 0.000 description 2
230000001276 controlling effect Effects 0.000 description 2
244000038559 crop plants Species 0.000 description 2
238000004132 cross linking Methods 0.000 description 2
XVOYSCVBGLVSOL-UHFFFAOYSA-N cysteic acid Chemical compound OC(=O)C(N)CS(O)(=O)=O XVOYSCVBGLVSOL-UHFFFAOYSA-N 0.000 description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
235000018417 cysteine Nutrition 0.000 description 2
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
210000000172 cytosol Anatomy 0.000 description 2
238000013461 design Methods 0.000 description 2
238000001514 detection method Methods 0.000 description 2
239000008121 dextrose Substances 0.000 description 2
235000014113 dietary fatty acids Nutrition 0.000 description 2
230000004069 differentiation Effects 0.000 description 2
239000003814 drug Substances 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
239000002158 endotoxin Substances 0.000 description 2
210000003722 extracellular fluid Anatomy 0.000 description 2
229930195729 fatty acid Natural products 0.000 description 2
239000000194 fatty acid Substances 0.000 description 2
150000004665 fatty acids Chemical class 0.000 description 2
239000000835 fiber Substances 0.000 description 2
230000008124 floral development Effects 0.000 description 2
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
230000037406 food intake Effects 0.000 description 2
230000005714 functional activity Effects 0.000 description 2
230000002538 fungal effect Effects 0.000 description 2
239000000417 fungicide Substances 0.000 description 2
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
238000010353 genetic engineering Methods 0.000 description 2
239000003862 glucocorticoid Substances 0.000 description 2
239000008103 glucose Substances 0.000 description 2
230000013595 glycosylation Effects 0.000 description 2
238000006206 glycosylation reaction Methods 0.000 description 2
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
238000004128 high performance liquid chromatography Methods 0.000 description 2
229920002674 hyaluronan Polymers 0.000 description 2
229960003160 hyaluronic acid Drugs 0.000 description 2
125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
230000016784 immunoglobulin production Effects 0.000 description 2
230000008676 import Effects 0.000 description 2
238000007901 in situ hybridization Methods 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
230000003993 interaction Effects 0.000 description 2
238000002955 isolation Methods 0.000 description 2
108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 2
239000008101 lactose Substances 0.000 description 2
108010083942 mannopine synthase Proteins 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
238000002844 melting Methods 0.000 description 2
230000008018 melting Effects 0.000 description 2
230000002503 metabolic effect Effects 0.000 description 2
239000002207 metabolite Substances 0.000 description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
150000002772 monosaccharides Chemical class 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
238000003199 nucleic acid amplification method Methods 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
235000016709 nutrition Nutrition 0.000 description 2
229920001778 nylon Polymers 0.000 description 2
239000001912 oat gum Substances 0.000 description 2
229940046166 oligodeoxynucleotide Drugs 0.000 description 2
238000011275 oncology therapy Methods 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
230000001717 pathogenic effect Effects 0.000 description 2
230000007030 peptide scission Effects 0.000 description 2
239000000575 pesticide Substances 0.000 description 2
238000002823 phage display Methods 0.000 description 2
239000012071 phase Substances 0.000 description 2
229920001983 poloxamer Polymers 0.000 description 2
229920000573 polyethylene Polymers 0.000 description 2
229920001282 polysaccharide Polymers 0.000 description 2
239000005017 polysaccharide Substances 0.000 description 2
150000004804 polysaccharides Chemical class 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
230000001376 precipitating effect Effects 0.000 description 2
238000011002 quantification Methods 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
238000002601 radiography Methods 0.000 description 2
239000011347 resin Substances 0.000 description 2
229920005989 resin Polymers 0.000 description 2
230000004044 response Effects 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
238000012552 review Methods 0.000 description 2
239000002336 ribonucleotide Substances 0.000 description 2
125000002652 ribonucleotide group Chemical group 0.000 description 2
FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
238000013077 scoring method Methods 0.000 description 2
238000012216 screening Methods 0.000 description 2
230000003248 secreting effect Effects 0.000 description 2
230000008117 seed development Effects 0.000 description 2
238000002864 sequence alignment Methods 0.000 description 2
230000019491 signal transduction Effects 0.000 description 2
239000002904 solvent Substances 0.000 description 2
239000008107 starch Substances 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
239000000758 substrate Substances 0.000 description 2
230000002194 synthesizing effect Effects 0.000 description 2
229920001059 synthetic polymer Polymers 0.000 description 2
229940037128 systemic glucocorticoids Drugs 0.000 description 2
150000003505 terpenes Chemical class 0.000 description 2
235000007586 terpenes Nutrition 0.000 description 2
238000012360 testing method Methods 0.000 description 2
229960002180 tetracycline Drugs 0.000 description 2
235000019364 tetracycline Nutrition 0.000 description 2
150000003522 tetracyclines Chemical class 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
238000010361 transduction Methods 0.000 description 2
230000026683 transduction Effects 0.000 description 2
230000032258 transport Effects 0.000 description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
239000003981 vehicle Substances 0.000 description 2
150000003722 vitamin derivatives Chemical class 0.000 description 2
239000002676 xenobiotic agent Substances 0.000 description 2
230000002034 xenobiotic effect Effects 0.000 description 2
OEANUJAFZLQYOD-CXAZCLJRSA-N (2r,3s,4r,5r,6r)-6-[(2r,3r,4r,5r,6r)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](OC)O[C@H](CO)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](OC)[C@H](C(O)=O)O1 OEANUJAFZLQYOD-CXAZCLJRSA-N 0.000 description 1
ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 1
BVAUMRCGVHUWOZ-ZETCQYMHSA-N (2s)-2-(cyclohexylazaniumyl)propanoate Chemical compound OC(=O)[C@H](C)NC1CCCCC1 BVAUMRCGVHUWOZ-ZETCQYMHSA-N 0.000 description 1
MRTPISKDZDHEQI-YFKPBYRVSA-N (2s)-2-(tert-butylamino)propanoic acid Chemical compound OC(=O)[C@H](C)NC(C)(C)C MRTPISKDZDHEQI-YFKPBYRVSA-N 0.000 description 1
NPDBDJFLKKQMCM-SCSAIBSYSA-N (2s)-2-amino-3,3-dimethylbutanoic acid Chemical compound CC(C)(C)[C@H](N)C(O)=O NPDBDJFLKKQMCM-SCSAIBSYSA-N 0.000 description 1
ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
GNYCTMYOHGBSBI-SVZOTFJBSA-N (3s,6r,9s,12r)-6,9-dimethyl-3-[6-[(2s)-oxiran-2-yl]-6-oxohexyl]-1,4,7,10-tetrazabicyclo[10.3.0]pentadecane-2,5,8,11-tetrone Chemical compound C([C@H]1C(=O)N2CCC[C@@H]2C(=O)N[C@H](C(N[C@H](C)C(=O)N1)=O)C)CCCCC(=O)[C@@H]1CO1 GNYCTMYOHGBSBI-SVZOTFJBSA-N 0.000 description 1
NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 1
VYEWZWBILJHHCU-OMQUDAQFSA-N (e)-n-[(2s,3r,4r,5r,6r)-2-[(2r,3r,4s,5s,6s)-3-acetamido-5-amino-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[2-[(2r,3s,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]-5-methylhex-2-enamide Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@H]2O)O)C(O)C[C@@H]2[C@H](O)[C@H](O)[C@H]([C@@H](O2)O[C@@H]2[C@@H]([C@@H](O)[C@H](N)[C@@H](CO)O2)NC(C)=O)NC(=O)/C=C/CC(C)C)C=CC(=O)NC1=O VYEWZWBILJHHCU-OMQUDAQFSA-N 0.000 description 1
102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
PUMZXCBVHLCWQG-UHFFFAOYSA-N 1-(4-Hydroxyphenyl)-2-aminoethanol hydrochloride Chemical compound [Cl-].[NH3+]CC(O)C1=CC=C(O)C=C1 PUMZXCBVHLCWQG-UHFFFAOYSA-N 0.000 description 1
UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
OGNSCSPNOLGXSM-UHFFFAOYSA-N 2,4-diaminobutyric acid Chemical compound NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
JLIDBLDQVAYHNE-LXGGSRJLSA-N 2-cis-abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\C1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-LXGGSRJLSA-N 0.000 description 1
ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical class OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
CKOMXBHMKXXTNW-UHFFFAOYSA-N 6-methyladenine Chemical compound CNC1=NC=NC2=C1N=CN2 CKOMXBHMKXXTNW-UHFFFAOYSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
241000724328 Alfalfa mosaic virus Species 0.000 description 1
239000004251 Ammonium lactate Substances 0.000 description 1
229920000945 Amylopectin Polymers 0.000 description 1
229920000856 Amylose Polymers 0.000 description 1
244000118350 Andrographis paniculata Species 0.000 description 1
241000207875 Antirrhinum Species 0.000 description 1
108700018853 Arabidopsis PR-1 Proteins 0.000 description 1
101100226680 Arabidopsis thaliana FACE1 gene Proteins 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
102100022717 Atypical chemokine receptor 1 Human genes 0.000 description 1
241000972773 Aulopiformes Species 0.000 description 1
229930192334 Auxin Natural products 0.000 description 1
238000012935 Averaging Methods 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
102100026189 Beta-galactosidase Human genes 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
235000011293 Brassica napus Nutrition 0.000 description 1
239000004322 Butylated hydroxytoluene Substances 0.000 description 1
108091028026 C-DNA Proteins 0.000 description 1
101100244725 Caenorhabditis elegans pef-1 gene Proteins 0.000 description 1
241001468265 Candidatus Phytoplasma Species 0.000 description 1
101710132601 Capsid protein Proteins 0.000 description 1
239000004215 Carbon black (E152) Substances 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
241000687983 Cerobasis alpha Species 0.000 description 1
108091092236 Chimeric RNA Proteins 0.000 description 1
229920002101 Chitin Polymers 0.000 description 1
229920002567 Chondroitin Polymers 0.000 description 1
108090000317 Chymotrypsin Proteins 0.000 description 1
101710094648 Coat protein Proteins 0.000 description 1
108020004394 Complementary RNA Proteins 0.000 description 1
241000186216 Corynebacterium Species 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
241000699802 Cricetulus griseus Species 0.000 description 1
UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
WQZGKKKJIJFFOK-CBPJZXOFSA-N D-Gulose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-CBPJZXOFSA-N 0.000 description 1
IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 description 1
WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 1
LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 description 1
YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 description 1
RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
HAIWUXASLYEWLM-UHFFFAOYSA-N D-manno-Heptulose Natural products OCC1OC(O)(CO)C(O)C(O)C1O HAIWUXASLYEWLM-UHFFFAOYSA-N 0.000 description 1
AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 1
ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
229920000045 Dermatan sulfate Polymers 0.000 description 1
YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
229920001353 Dextrin Polymers 0.000 description 1
239000004375 Dextrin Substances 0.000 description 1
238000009007 Diagnostic Kit Methods 0.000 description 1
BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
241001057636 Dracaena deremensis Species 0.000 description 1
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
101710202200 Endolysin A Proteins 0.000 description 1
101710091045 Envelope protein Proteins 0.000 description 1
YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
206010056474 Erythrosis Diseases 0.000 description 1
241000701959 Escherichia virus Lambda Species 0.000 description 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
239000005977 Ethylene Substances 0.000 description 1
XZWYTXMRWQJBGX-VXBMVYAYSA-N FLAG peptide Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=C(O)C=C1 XZWYTXMRWQJBGX-VXBMVYAYSA-N 0.000 description 1
239000004230 Fast Yellow AB Substances 0.000 description 1
241000701484 Figwort mosaic virus Species 0.000 description 1
BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
229920002670 Fructan Polymers 0.000 description 1
229920000855 Fucoidan Polymers 0.000 description 1
229930182566 Gentamicin Natural products 0.000 description 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
229920001503 Glucan Polymers 0.000 description 1
239000004366 Glucose oxidase Substances 0.000 description 1
108010015776 Glucose oxidase Proteins 0.000 description 1
108010051815 Glutamyl endopeptidase Proteins 0.000 description 1
JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
229920002527 Glycogen Polymers 0.000 description 1
229930186217 Glycolipid Natural products 0.000 description 1
102000002068 Glycopeptides Human genes 0.000 description 1
108010015899 Glycopeptides Proteins 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
229920002683 Glycosaminoglycan Polymers 0.000 description 1
102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
108010051041 HC toxin Proteins 0.000 description 1
208000031886 HIV Infections Diseases 0.000 description 1
208000037357 HIV infectious disease Diseases 0.000 description 1
101710154606 Hemagglutinin Proteins 0.000 description 1
230000010556 Heparin Binding Activity Effects 0.000 description 1
SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
101000678879 Homo sapiens Atypical chemokine receptor 1 Proteins 0.000 description 1
101000899240 Homo sapiens Endoplasmic reticulum chaperone BiP Proteins 0.000 description 1
101000740215 Homo sapiens Sodium/myo-inositol cotransporter 2 Proteins 0.000 description 1
101000617823 Homo sapiens Solute carrier organic anion transporter family member 6A1 Proteins 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
108700005091 Immunoglobulin Genes Proteins 0.000 description 1
102000012745 Immunoglobulin Subunits Human genes 0.000 description 1
108010079585 Immunoglobulin Subunits Proteins 0.000 description 1
229930010555 Inosine Natural products 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
102100034349 Integrase Human genes 0.000 description 1
102000008070 Interferon-gamma Human genes 0.000 description 1
108010074328 Interferon-gamma Proteins 0.000 description 1
108010050904 Interferons Proteins 0.000 description 1
102000014150 Interferons Human genes 0.000 description 1
102000000588 Interleukin-2 Human genes 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
229920001202 Inulin Polymers 0.000 description 1
108010076876 Keratins Proteins 0.000 description 1
102000011782 Keratins Human genes 0.000 description 1
208000007976 Ketosis Diseases 0.000 description 1
241000235058 Komagataella pastoris Species 0.000 description 1
LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
WQZGKKKJIJFFOK-VSOAQEOCSA-N L-altropyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-VSOAQEOCSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
HSNZZMHEPUFJNZ-UHFFFAOYSA-N L-galacto-2-Heptulose Natural products OCC(O)C(O)C(O)C(O)C(=O)CO HSNZZMHEPUFJNZ-UHFFFAOYSA-N 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 1
241000710118 Maize chlorotic mottle virus Species 0.000 description 1
241000723994 Maize dwarf mosaic virus Species 0.000 description 1
101710125418 Major capsid protein Proteins 0.000 description 1
101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
229920000057 Mannan Polymers 0.000 description 1
CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
108091061960 Naked DNA Proteins 0.000 description 1
RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
229930193140 Neomycin Natural products 0.000 description 1
108700019961 Neoplasm Genes Proteins 0.000 description 1
102000048850 Neoplasm Genes Human genes 0.000 description 1
208000009869 Neu-Laxova syndrome Diseases 0.000 description 1
101100020663 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ppm-1 gene Proteins 0.000 description 1
108091092724 Noncoding DNA Proteins 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
101710141454 Nucleoprotein Proteins 0.000 description 1
108020005187 Oligonucleotide Probes Proteins 0.000 description 1
AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
241000209094 Oryza Species 0.000 description 1
101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
108090000526 Papain Proteins 0.000 description 1
241001503547 Pear latent virus Species 0.000 description 1
229920002230 Pectic acid Polymers 0.000 description 1
102000007079 Peptide Fragments Human genes 0.000 description 1
108010033276 Peptide Fragments Proteins 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
241000709664 Picornaviridae Species 0.000 description 1
108700001094 Plant Genes Proteins 0.000 description 1
241000276498 Pollachius virens Species 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
229920001100 Polydextrose Polymers 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
239000004236 Ponceau SX Substances 0.000 description 1
241000710078 Potyvirus Species 0.000 description 1
101710083689 Probable capsid protein Proteins 0.000 description 1
101710176177 Protein A56 Proteins 0.000 description 1
108010029485 Protein Isoforms Proteins 0.000 description 1
102000001708 Protein Isoforms Human genes 0.000 description 1
108700040121 Protein Methyltransferases Proteins 0.000 description 1
102000055027 Protein Methyltransferases Human genes 0.000 description 1
101710188315 Protein X Proteins 0.000 description 1
229940116193 Protein phosphatase inhibitor Drugs 0.000 description 1
101100084022 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) lapA gene Proteins 0.000 description 1
229920001218 Pullulan Polymers 0.000 description 1
239000004373 Pullulan Substances 0.000 description 1
LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
241000700159 Rattus Species 0.000 description 1
101100510671 Rattus norvegicus Lnpep gene Proteins 0.000 description 1
108700008625 Reporter Genes Proteins 0.000 description 1
108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 1
108010039491 Ricin Proteins 0.000 description 1
241000235070 Saccharomyces Species 0.000 description 1
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
108010084592 Saporins Proteins 0.000 description 1
108010077895 Sarcosine Proteins 0.000 description 1
108091058545 Secretory proteins Proteins 0.000 description 1
102000040739 Secretory proteins Human genes 0.000 description 1
HAIWUXASLYEWLM-AZEWMMITSA-N Sedoheptulose Natural products OC[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@](O)(CO)O1 HAIWUXASLYEWLM-AZEWMMITSA-N 0.000 description 1
101710150104 Sensory rhodopsin-1 Proteins 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
239000004288 Sodium dehydroacetate Substances 0.000 description 1
102100037202 Sodium/myo-inositol cotransporter 2 Human genes 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
241000256248 Spodoptera Species 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
241000187747 Streptomyces Species 0.000 description 1
208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
108020005038 Terminator Codon Proteins 0.000 description 1
102100036407 Thioredoxin Human genes 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
108010022394 Threonine synthase Proteins 0.000 description 1
108010034949 Thyroglobulin Proteins 0.000 description 1
102000009843 Thyroglobulin Human genes 0.000 description 1
241000723873 Tobacco mosaic virus Species 0.000 description 1
101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
229940122618 Trypsin inhibitor Drugs 0.000 description 1
101710162629 Trypsin inhibitor Proteins 0.000 description 1
YJQCOFNZVFGCAF-UHFFFAOYSA-N Tunicamycin II Natural products O1C(CC(O)C2C(C(O)C(O2)N2C(NC(=O)C=C2)=O)O)C(O)C(O)C(NC(=O)C=CCCCCCCCCC(C)C)C1OC1OC(CO)C(O)C(O)C1NC(C)=O YJQCOFNZVFGCAF-UHFFFAOYSA-N 0.000 description 1
101150057897 USP gene Proteins 0.000 description 1
230000006750 UV protection Effects 0.000 description 1
229910052770 Uranium Inorganic materials 0.000 description 1
DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 1
241000607479 Yersinia pestis Species 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000012190 activator Substances 0.000 description 1
239000013543 active substance Substances 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
230000002411 adverse Effects 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
230000009418 agronomic effect Effects 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
238000012867 alanine scanning Methods 0.000 description 1
IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
150000001323 aldoses Chemical class 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
230000002009 allergenic effect Effects 0.000 description 1
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
230000009435 amidation Effects 0.000 description 1
238000007112 amidation reaction Methods 0.000 description 1
150000001408 amides Chemical group 0.000 description 1
235000005550 amino acid supplement Nutrition 0.000 description 1
229960002684 aminocaproic acid Drugs 0.000 description 1
229960003896 aminopterin Drugs 0.000 description 1
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
229910052921 ammonium sulfate Inorganic materials 0.000 description 1
238000012870 ammonium sulfate precipitation Methods 0.000 description 1
235000011130 ammonium sulphate Nutrition 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
238000005571 anion exchange chromatography Methods 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
238000000137 annealing Methods 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000003172 anti-dna Effects 0.000 description 1
230000003302 anti-idiotype Effects 0.000 description 1
230000000884 anti-protozoa Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
210000000628 antibody-producing cell Anatomy 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
239000003429 antifungal agent Substances 0.000 description 1
239000000074 antisense oligonucleotide Substances 0.000 description 1
238000012230 antisense oligonucleotides Methods 0.000 description 1
239000003443 antiviral agent Substances 0.000 description 1
239000008365 aqueous carrier Substances 0.000 description 1
238000003491 array Methods 0.000 description 1
210000004507 artificial chromosome Anatomy 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
230000003416 augmentation Effects 0.000 description 1
239000002363 auxin Substances 0.000 description 1
229910052788 barium Inorganic materials 0.000 description 1
DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
230000001588 bifunctional effect Effects 0.000 description 1
GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
239000012867 bioactive agent Substances 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
229910052792 caesium Inorganic materials 0.000 description 1
TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
235000010410 calcium alginate Nutrition 0.000 description 1
239000000648 calcium alginate Substances 0.000 description 1
229960002681 calcium alginate Drugs 0.000 description 1
OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
230000034149 carbohydrate storage Effects 0.000 description 1
239000004106 carminic acid Substances 0.000 description 1
235000010418 carrageenan Nutrition 0.000 description 1
229920001525 carrageenan Polymers 0.000 description 1
239000000679 carrageenan Substances 0.000 description 1
229940113118 carrageenan Drugs 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
238000005277 cation exchange chromatography Methods 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
239000012707 chemical precursor Substances 0.000 description 1
VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
229960001231 choline Drugs 0.000 description 1
OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
230000008711 chromosomal rearrangement Effects 0.000 description 1
238000003200 chromosome mapping Methods 0.000 description 1
229960002376 chymotrypsin Drugs 0.000 description 1
229960002173 citrulline Drugs 0.000 description 1
235000013477 citrulline Nutrition 0.000 description 1
230000004186 co-expression Effects 0.000 description 1
230000008645 cold stress Effects 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
238000012875 competitive assay Methods 0.000 description 1
230000001268 conjugating effect Effects 0.000 description 1
238000011109 contamination Methods 0.000 description 1
239000002872 contrast media Substances 0.000 description 1
239000003431 cross linking reagent Substances 0.000 description 1
238000012258 culturing Methods 0.000 description 1
ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
150000001945 cysteines Chemical class 0.000 description 1
UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
229940104302 cytosine Drugs 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
239000008367 deionised water Substances 0.000 description 1
229910021641 deionized water Inorganic materials 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
238000002716 delivery method Methods 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000000151 deposition Methods 0.000 description 1
238000001212 derivatisation Methods 0.000 description 1
229910052805 deuterium Inorganic materials 0.000 description 1
229960003957 dexamethasone Drugs 0.000 description 1
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
235000019425 dextrin Nutrition 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
238000010586 diagram Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
UMGXUWVIJIQANV-UHFFFAOYSA-M didecyl(dimethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC UMGXUWVIJIQANV-UHFFFAOYSA-M 0.000 description 1
230000029087 digestion Effects 0.000 description 1
229940079920 digestives acid preparations Drugs 0.000 description 1
102000004419 dihydrofolate reductase Human genes 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
229910001873 dinitrogen Inorganic materials 0.000 description 1
MWRBNPKJOOWZPW-CLFAGFIQSA-N dioleoyl phosphatidylethanolamine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(=O)OCCN)OC(=O)CCCCCCC\C=C/CCCCCCCC MWRBNPKJOOWZPW-CLFAGFIQSA-N 0.000 description 1
150000002016 disaccharides Chemical class 0.000 description 1
125000002228 disulfide group Chemical group 0.000 description 1
PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
230000008641 drought stress Effects 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
238000007876 drug discovery Methods 0.000 description 1
238000001035 drying Methods 0.000 description 1
235000013399 edible fruits Nutrition 0.000 description 1
238000000804 electron spin resonance spectroscopy Methods 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
208000001901 epithelial recurrent erosion dystrophy Diseases 0.000 description 1
239000004318 erythorbic acid Substances 0.000 description 1
UQPHVQVXLPRNCX-UHFFFAOYSA-N erythrulose Chemical compound OCC(O)C(=O)CO UQPHVQVXLPRNCX-UHFFFAOYSA-N 0.000 description 1
238000012869 ethanol precipitation Methods 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
239000000284 extract Substances 0.000 description 1
238000000605 extraction Methods 0.000 description 1
238000001125 extrusion Methods 0.000 description 1
210000000416 exudates and transudate Anatomy 0.000 description 1
239000010408 film Substances 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
235000019634 flavors Nutrition 0.000 description 1
229910052587 fluorapatite Inorganic materials 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
230000004907 flux Effects 0.000 description 1
235000013305 food Nutrition 0.000 description 1
230000037433 frameshift Effects 0.000 description 1
PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
235000015203 fruit juice Nutrition 0.000 description 1
230000000855 fungicidal effect Effects 0.000 description 1
229930182830 galactose Natural products 0.000 description 1
229960003692 gamma aminobutyric acid Drugs 0.000 description 1
125000002421 ganglioside group Chemical group 0.000 description 1
239000007789 gas Substances 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
238000007429 general method Methods 0.000 description 1
238000003205 genotyping method Methods 0.000 description 1
230000035784 germination Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000000174 gluconic acid Substances 0.000 description 1
235000012208 gluconic acid Nutrition 0.000 description 1
229960002442 glucosamine Drugs 0.000 description 1
229940116332 glucose oxidase Drugs 0.000 description 1
235000019420 glucose oxidase Nutrition 0.000 description 1
229940097043 glucuronic acid Drugs 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
229940096919 glycogen Drugs 0.000 description 1
230000034659 glycolysis Effects 0.000 description 1
XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
230000008642 heat stress Effects 0.000 description 1
229910001385 heavy metal Inorganic materials 0.000 description 1
GNYCTMYOHGBSBI-UHFFFAOYSA-N helminthsporium carbonum toxin Natural products N1C(=O)C(C)NC(=O)C(C)NC(=O)C2CCCN2C(=O)C1CCCCCC(=O)C1CO1 GNYCTMYOHGBSBI-UHFFFAOYSA-N 0.000 description 1
239000008241 heterogeneous mixture Substances 0.000 description 1
229920000140 heteropolymer Polymers 0.000 description 1
238000012188 high-throughput screening assay Methods 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
238000002744 homologous recombination Methods 0.000 description 1
230000006801 homologous recombination Effects 0.000 description 1
229920001519 homopolymer Polymers 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
210000003917 human chromosome Anatomy 0.000 description 1
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
238000011577 humanized mouse model Methods 0.000 description 1
210000004754 hybrid cell Anatomy 0.000 description 1
230000000887 hydrating effect Effects 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
125000004356 hydroxy functional group Chemical group O* 0.000 description 1
229910052588 hydroxylapatite Inorganic materials 0.000 description 1
238000012872 hydroxylapatite chromatography Methods 0.000 description 1
229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
229960002591 hydroxyproline Drugs 0.000 description 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
230000007954 hypoxia Effects 0.000 description 1
150000002454 idoses Chemical class 0.000 description 1
230000036039 immunity Effects 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
239000000367 immunologic factor Substances 0.000 description 1
239000002596 immunotoxin Substances 0.000 description 1
230000002637 immunotoxin Effects 0.000 description 1
231100000608 immunotoxin Toxicity 0.000 description 1
229940051026 immunotoxin Drugs 0.000 description 1
238000011503 in vivo imaging Methods 0.000 description 1
229910052738 indium Inorganic materials 0.000 description 1
APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
230000006698 induction Effects 0.000 description 1
206010022000 influenza Diseases 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
229960000367 inositol Drugs 0.000 description 1
CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
230000005732 intercellular adhesion Effects 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
229960003130 interferon gamma Drugs 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
230000010189 intracellular transport Effects 0.000 description 1
239000007928 intraperitoneal injection Substances 0.000 description 1
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
229940029339 inulin Drugs 0.000 description 1
239000011630 iodine Substances 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
239000004313 iron ammonium citrate Substances 0.000 description 1
238000005304 joining Methods 0.000 description 1
BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
BQINXKOTJQCISL-GRCPKETISA-N keto-neuraminic acid Chemical compound OC(=O)C(=O)C[C@H](O)[C@@H](N)[C@@H](O)[C@H](O)[C@H](O)CO BQINXKOTJQCISL-GRCPKETISA-N 0.000 description 1
150000002584 ketoses Chemical class 0.000 description 1
238000002372 labelling Methods 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 1
230000037356 lipid metabolism Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
LUEWUZLMQUOBSB-GFVSVBBRSA-N mannan Chemical class O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 description 1
238000004949 mass spectrometry Methods 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
230000031864 metaphase Effects 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
QLOAVXSYZAJECW-UHFFFAOYSA-N methane;molecular fluorine Chemical compound C.FF QLOAVXSYZAJECW-UHFFFAOYSA-N 0.000 description 1
229960000485 methotrexate Drugs 0.000 description 1
DFTAZNAEBRBBKP-UHFFFAOYSA-N methyl 4-sulfanylbutanimidate Chemical compound COC(=N)CCCS DFTAZNAEBRBBKP-UHFFFAOYSA-N 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
238000012775 microarray technology Methods 0.000 description 1
239000011707 mineral Substances 0.000 description 1
230000033607 mismatch repair Effects 0.000 description 1
238000001823 molecular biology technique Methods 0.000 description 1
239000002808 molecular sieve Substances 0.000 description 1
229940035032 monophosphoryl lipid a Drugs 0.000 description 1
235000019799 monosodium phosphate Nutrition 0.000 description 1
238000002887 multiple sequence alignment Methods 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
230000000869 mutational effect Effects 0.000 description 1
229920005615 natural polymer Polymers 0.000 description 1
229960004927 neomycin Drugs 0.000 description 1
CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
108091027963 non-coding RNA Proteins 0.000 description 1
102000042567 non-coding RNA Human genes 0.000 description 1
108010058731 nopaline synthase Proteins 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
125000003835 nucleoside group Chemical group 0.000 description 1
229960001576 octopamine Drugs 0.000 description 1
QNDVLZJODHBUFM-WFXQOWMNSA-N okadaic acid Chemical compound C([C@H](O1)[C@H](C)/C=C/[C@H]2CC[C@@]3(CC[C@H]4O[C@@H](C([C@@H](O)[C@@H]4O3)=C)[C@@H](O)C[C@H](C)[C@@H]3[C@@H](CC[C@@]4(OCCCC4)O3)C)O2)C(C)=C[C@]21O[C@H](C[C@@](C)(O)C(O)=O)CC[C@H]2O QNDVLZJODHBUFM-WFXQOWMNSA-N 0.000 description 1
VEFJHAYOIAAXEU-UHFFFAOYSA-N okadaic acid Natural products CC(CC(O)C1OC2CCC3(CCC(O3)C=CC(C)C4CC(=CC5(OC(CC(C)(O)C(=O)O)CCC5O)O4)C)OC2C(O)C1C)C6OC7(CCCCO7)CCC6C VEFJHAYOIAAXEU-UHFFFAOYSA-N 0.000 description 1
239000002751 oligonucleotide probe Substances 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
210000003463 organelle Anatomy 0.000 description 1
229960003104 ornithine Drugs 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
238000012261 overproduction Methods 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
230000036542 oxidative stress Effects 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
235000019629 palatability Nutrition 0.000 description 1
229940055729 papain Drugs 0.000 description 1
235000019834 papain Nutrition 0.000 description 1
244000052769 pathogen Species 0.000 description 1
LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
229920001277 pectin Polymers 0.000 description 1
239000001814 pectin Substances 0.000 description 1
235000010987 pectin Nutrition 0.000 description 1
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
230000008447 perception Effects 0.000 description 1
210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
230000002688 persistence Effects 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
101150009573 phoA gene Proteins 0.000 description 1
125000001095 phosphatidyl group Chemical group 0.000 description 1
150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
229940080469 phosphocellulose Drugs 0.000 description 1
150000004713 phosphodiesters Chemical group 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
239000003934 phosphoprotein phosphatase inhibitor Substances 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
229910001392 phosphorus oxide Inorganic materials 0.000 description 1
LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical class [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
230000035479 physiological effects, processes and functions Effects 0.000 description 1
229930195732 phytohormone Natural products 0.000 description 1
238000003976 plant breeding Methods 0.000 description 1
239000003375 plant hormone Substances 0.000 description 1
230000037039 plant physiology Effects 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
229920000747 poly(lactic acid) Polymers 0.000 description 1
229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
229920002627 poly(phosphazenes) Polymers 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
229920000768 polyamine Polymers 0.000 description 1
229920000447 polyanionic polymer Polymers 0.000 description 1
235000013856 polydextrose Nutrition 0.000 description 1
239000001259 polydextrose Substances 0.000 description 1
229940035035 polydextrose Drugs 0.000 description 1
239000010318 polygalacturonic acid Substances 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
239000004926 polymethyl methacrylate Substances 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920001451 polypropylene glycol Polymers 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
229950008882 polysorbate Drugs 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
229920001343 polytetrafluoroethylene Polymers 0.000 description 1
239000004810 polytetrafluoroethylene Substances 0.000 description 1
229920002635 polyurethane Polymers 0.000 description 1
239000004814 polyurethane Substances 0.000 description 1
229920000915 polyvinyl chloride Polymers 0.000 description 1
239000004800 polyvinyl chloride Substances 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
230000032962 positive regulation of cell cycle Effects 0.000 description 1
230000004481 post-translational protein modification Effects 0.000 description 1
239000001608 potassium adipate Substances 0.000 description 1
239000001508 potassium citrate Substances 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
238000002953 preparative HPLC Methods 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
230000004845 protein aggregation Effects 0.000 description 1
238000000159 protein binding assay Methods 0.000 description 1
230000012846 protein folding Effects 0.000 description 1
230000012743 protein tagging Effects 0.000 description 1
230000004850 protein–protein interaction Effects 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
230000006337 proteolytic cleavage Effects 0.000 description 1
235000019423 pullulan Nutrition 0.000 description 1
230000005855 radiation Effects 0.000 description 1
238000002708 random mutagenesis Methods 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
238000003259 recombinant expression Methods 0.000 description 1
239000004180 red 2G Substances 0.000 description 1
238000006722 reduction reaction Methods 0.000 description 1
230000029892 regulation of protein phosphorylation Effects 0.000 description 1
230000007363 regulatory process Effects 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
230000003938 response to stress Effects 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
230000002786 root growth Effects 0.000 description 1
210000003935 rough endoplasmic reticulum Anatomy 0.000 description 1
235000019515 salmon Nutrition 0.000 description 1
229940043230 sarcosine Drugs 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
238000013391 scatchard analysis Methods 0.000 description 1
CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
230000028327 secretion Effects 0.000 description 1
HSNZZMHEPUFJNZ-SHUUEZRQSA-N sedoheptulose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO HSNZZMHEPUFJNZ-SHUUEZRQSA-N 0.000 description 1
230000009758 senescence Effects 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
235000010413 sodium alginate Nutrition 0.000 description 1
239000000661 sodium alginate Substances 0.000 description 1
URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
239000012279 sodium borohydride Substances 0.000 description 1
229910000033 sodium borohydride Inorganic materials 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
229940048086 sodium pyrophosphate Drugs 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
230000000392 somatic effect Effects 0.000 description 1
229960000268 spectinomycin Drugs 0.000 description 1
UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
210000004989 spleen cell Anatomy 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000007858 starting material Substances 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
230000015378 stomatal closure Effects 0.000 description 1
230000004960 subcellular localization Effects 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
150000005846 sugar alcohols Chemical class 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
239000013589 supplement Substances 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
239000001648 tannin Substances 0.000 description 1
235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
229940126585 therapeutic drug Drugs 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
239000010409 thin film Substances 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
108060008226 thioredoxin Proteins 0.000 description 1
229940094937 thioredoxin Drugs 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
229960002175 thyroglobulin Drugs 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
230000005026 transcription initiation Effects 0.000 description 1
230000005030 transcription termination Effects 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
230000005945 translocation Effects 0.000 description 1
230000005068 transpiration Effects 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
229910052722 tritium Inorganic materials 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
229960001322 trypsin Drugs 0.000 description 1
239000002753 trypsin inhibitor Substances 0.000 description 1
239000000814 tuberculostatic agent Substances 0.000 description 1
MEYZYGMYMLNUHJ-UHFFFAOYSA-N tunicamycin Natural products CC(C)CCCCCCCCCC=CC(=O)NC1C(O)C(O)C(CC(O)C2OC(C(O)C2O)N3C=CC(=O)NC3=O)OC1OC4OC(CO)C(O)C(O)C4NC(=O)C MEYZYGMYMLNUHJ-UHFFFAOYSA-N 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
229940045145 uridine Drugs 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
210000003934 vacuole Anatomy 0.000 description 1
230000002792 vascular Effects 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
239000011534 wash buffer Substances 0.000 description 1
238000001262 western blot Methods 0.000 description 1
229920001221 xylan Polymers 0.000 description 1
150000004823 xylans Chemical class 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1
UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8273—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for drought, cold, salt resistance
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Cell Biology (AREA)
Physics & Mathematics (AREA)
Mycology (AREA)
Plant Pathology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Enzymes And Modification Thereof (AREA)
Transmission And Conversion Of Sensor Element Output (AREA)
Optical Transform (AREA)
Analogue/Digital Conversion (AREA)

ZA200301579A 2000-08-25 2001-08-27 Plant polynucleotides encoding prenyl proteases. ZA200301579B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US22779400P	2000-08-25	2000-08-25

Publications (1)

Publication Number	Publication Date
ZA200301579B true ZA200301579B (en)	2004-06-21

Family

ID=22854490

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200301579A ZA200301579B (en)	2000-08-25	2001-08-27	Plant polynucleotides encoding prenyl proteases.

Country Status (13)

Country	Link
US (1)	US20040219525A1 (de)
EP (2)	EP1349946B1 (de)
JP (1)	JP4932125B2 (de)
CN (1)	CN1564869A (de)
AT (1)	ATE497007T1 (de)
AU (2)	AU8847801A (de)
BR (1)	BR0113512A (de)
CA (1)	CA2420325A1 (de)
DE (1)	DE60143959D1 (de)
ES (1)	ES2361925T3 (de)
IL (2)	IL154596A0 (de)
WO (1)	WO2002016625A2 (de)
ZA (1)	ZA200301579B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7262338B2 (en)	1998-11-13	2007-08-28	Performance Plants, Inc.	Stress tolerance and delayed senescence in plants
US7951991B2 (en)	2000-08-25	2011-05-31	Basf Plant Science Gmbh	Polynucleotides encoding plant prenyl proteases
ATE429502T1 (de)	2001-05-31	2009-05-15	Performance Plants Inc	Zusammensetzungen und methoden für eine erhöhung der stresstoleranz in pflanzen
WO2003012116A2 (en) *	2001-08-01	2003-02-13	Performance Plants, Inc.	Caax prenyl protease nucleic acids and polypeptides and methods of use thereof
US20080035787A1 (en) *	2006-08-08	2008-02-14	Thompson Mark N	Lighter-than-air gas handling system and method
US20080179453A1 (en) *	2007-01-26	2008-07-31	Thompson Mark N	Modular airship system and method
TWI461437B (zh) *	2010-04-09	2014-11-21	Univ Nat Taiwan	快速萃取褐藻糖膠之方法
CN102586266B (zh) *	2011-01-13	2013-09-18	中国科学院遗传与发育生物学研究所	拟南芥白粉病抗性相关基因edr6的克隆及应用
US9580758B2 (en)	2013-11-12	2017-02-28	Luc Montagnier	System and method for the detection and treatment of infection by a microbial agent associated with HIV infection
JP7603025B2 (ja) *	2019-06-20	2024-12-19	ユーシービーバイオファルマエスアールエル	タンパク質試料におけるｈｐｌｃに基づく凝集剤の検出
CN111117940B (zh) *	2019-12-04	2022-06-28	天津大学	一种高产戊二胺的大肠杆菌工程菌与方法
PT4039093T (pt) *	2021-02-09	2023-10-20	Biobab R&D S L Star	Método e utilização de enantiómeros de 3,4-dihidroxifenilalanina (dopa) para aumentar a atratividade das plantas para insetos benéficos
CN113832036B (zh) *	2021-09-16	2023-08-22	王善仙	一种露湿漆斑菌clf007、固定化微生物菌剂及其应用
WO2024026038A2 (en) *	2022-07-29	2024-02-01	The Regents Of The University Of California	Needle-laden plant inoculation method

Family Cites Families (146)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4376110A (en)	1980-08-04	1983-03-08	Hybritech, Incorporated	Immunometric assays using monoclonal antibodies
GB8308235D0 (en)	1983-03-25	1983-05-05	Celltech Ltd	Polypeptides
US4816567A (en)	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
US5380831A (en)	1986-04-04	1995-01-10	Mycogen Plant Science, Inc.	Synthetic insecticidal crystal protein gene
JPS6147500A (ja)	1984-08-15	1986-03-07	Res Dev Corp Of Japan	キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (de)	1984-08-27	1987-11-25	The Board Of Trustees Of The Leland Stanford Junior University	Chimäre Rezeptoren durch Verbindung und Expression von DNS
GB8422238D0 (en)	1984-09-03	1984-10-10	Neuberger M S	Chimeric proteins
GB8426467D0 (en)	1984-10-19	1984-11-28	Technology Licence Co Ltd	Monoclonal antibodies
US5049386A (en)	1985-01-07	1991-09-17	Syntex (U.S.A.) Inc.	N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4897355A (en)	1985-01-07	1990-01-30	Syntex (U.S.A.) Inc.	N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4946787A (en)	1985-01-07	1990-08-07	Syntex (U.S.A.) Inc.	N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5753475A (en)	1985-01-17	1998-05-19	Calgene, Inc.	Methods and compositions for regulated transcription and expression of heterologous genes
US4683195A (en)	1986-01-30	1987-07-28	Cetus Corporation	Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5182200A (en)	1985-04-22	1993-01-26	Lubrizol Genetics, Inc.	T-dna promoters
EP0232262A4 (de)	1985-08-15	1989-09-19	Stauffer Chemical Co	Tryptophan erzeugender mikroorganismus.
US4676980A (en)	1985-09-23	1987-06-30	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Target specific cross-linked heteroantibodies
EP0247091B1 (de)	1985-11-01	1993-09-29	Xoma Corporation	Modulare einheit von antikörpergenen, daraus hergestellte antikörper und verwendung
US4795855A (en)	1985-11-14	1989-01-03	Joanne Fillatti	Transformation and foreign gene expression with woody species
DE3786898T2 (de)	1986-05-29	1994-02-10	Calgene Inc	TRANSFORMATION UND EXPRESSION EINES FREMDEN GENS IN -i(BRASSICA) SPEZIES.
AU7335187A (en)	1986-06-10	1987-12-17	Calgene, Inc.	Agrobacterium transformation of plant tissue
US4902505A (en)	1986-07-30	1990-02-20	Alkermes	Chimeric peptides for neuropeptide delivery through the blood-brain barrier
US5268463A (en)	1986-11-11	1993-12-07	Jefferson Richard A	Plant promoter α-glucuronidase gene construct
US5116742A (en)	1986-12-03	1992-05-26	University Patents, Inc.	RNA ribozyme restriction endoribonucleases and methods
ATE169955T1 (de)	1987-05-20	1998-09-15	Ciba Geigy Ag	Verfahren zur herstellug von transgene zea mays- pflanzen, die aus protoplasten oder aus von protopflasten erhaltenen zellen regeneriert wurden
US4904582A (en)	1987-06-11	1990-02-27	Synthetic Genetics	Novel amphiphilic nucleic acid conjugates
JP3026985B2 (ja)	1987-10-20	2000-03-27	プラント・ジェネティック・システムズ・エヌ・ブイ	遺伝子導入植物内の修飾された貯蔵種子タンパク質遺伝子の発現による生物学的に活性なペプチドの製造方法
DE3855591T2 (de)	1987-10-20	1997-04-03	Plant Genetic Systems Nv	Verfahren zur Herstellung eines biologisch-aktiven Peptides durch Expression von modifizierten Speicherproteingenen in transgenetischen Pflanzen
US5614395A (en)	1988-03-08	1997-03-25	Ciba-Geigy Corporation	Chemically regulatable and anti-pathogenic DNA sequences and uses thereof
DE58909753D1 (de)	1988-03-08	1997-01-23	Ciba Geigy Ag	Regeneration von fertilen Gramineen-Pflanzen aus der Unterfamilie Pooideae ausgehend von Protoplasten
US5789214A (en)	1988-03-08	1998-08-04	Novartis Finance Corporation	Method of inducing gene transcription in a plant
GB8810120D0 (en)	1988-04-28	1988-06-02	Plant Genetic Systems Nv	Transgenic nuclear male sterile plants
NZ230375A (en)	1988-09-09	1991-07-26	Lubrizol Genetics Inc	Synthetic gene encoding b. thuringiensis insecticidal protein
GB8823869D0 (en)	1988-10-12	1988-11-16	Medical Res Council	Production of antibodies
US5723757A (en)	1988-12-21	1998-03-03	Hoechst Schering Agrevo Gmbh	Plant promoters specific for sink organ expression of genes
EP1103616A3 (de)	1989-02-24	2001-06-27	Monsanto Company	Synthetische Pflanzengene und Verfahren zu ihrer Herstellung
EP0737750B1 (de)	1989-03-21	2003-05-14	Vical, Inc.	Expression von exogenen Polynukleotidsequenzen in Wirbeltieren
US5693622A (en)	1989-03-21	1997-12-02	Vical Incorporated	Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US5703055A (en)	1989-03-21	1997-12-30	Wisconsin Alumni Research Foundation	Generation of antibodies through lipid mediated DNA delivery
DK0392225T3 (da)	1989-03-24	2003-09-22	Syngenta Participations Ag	Sygdomsresistente transgene planter
EP0394827A1 (de)	1989-04-26	1990-10-31	F. Hoffmann-La Roche Ag	Chimärische CD4-Immunoglobulin-Polypeptide
EP0479909B1 (de)	1989-06-29	1996-10-30	Medarex, Inc.	Bispezifische reagenzien für die aids-therapie
DE69033667T2 (de)	1989-08-04	2001-03-29	Aventis Cropscience N.V., Gent	Pflanzen mit modifizierten Blüten, Samen oder Embryos
US5959177A (en)	1989-10-27	1999-09-28	The Scripps Research Institute	Transgenic plants expressing assembled secretory antibodies
US5676954A (en)	1989-11-03	1997-10-14	Vanderbilt University	Method of in vivo delivery of functioning foreign genes
US5284746A (en)	1990-02-08	1994-02-08	Zymogenetics, Inc.	Methods of producing hybrid G protein-coupled receptors
CA2080584C (en)	1990-04-18	2000-09-05	Marc Cornelissen	Modified bacillus thuringiensis insecticidal-crystal protein genes and their expression in plant cells
US5264618A (en)	1990-04-19	1993-11-23	Vical, Inc.	Cationic lipids for intracellular delivery of biologically active molecules
ATE169030T1 (de)	1990-06-28	1998-08-15	Hoechst Ag	Fusionsproteine mit immunglobulinanteilen, ihre herstellung und verwendung
US5545806A (en)	1990-08-29	1996-08-13	Genpharm International, Inc.	Ransgenic non-human animals for producing heterologous antibodies
US5633425A (en)	1990-08-29	1997-05-27	Genpharm International, Inc.	Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en)	1990-08-29	1997-04-29	Genpharm International, Inc.	Transgenic non-human animals for producing heterologous antibodies
AU8507191A (en)	1990-08-29	1992-03-30	Genpharm International, Inc.	Transgenic non-human animals capable of producing heterologous antibodies
GB9028060D0 (en)	1990-12-24	1991-02-13	Nickerson Int Seed	Recombinant dna
US5589610A (en)	1991-02-07	1996-12-31	Plant Genetic Systems, N.V.	Stamen-specific promoters from corn
JP3462497B2 (ja)	1991-02-08	2003-11-05	バイエル・バイオサイエンス・エヌ・ヴェー	コメ由来の雄ずい特異的プロモーター
US5205290A (en)	1991-04-05	1993-04-27	Unger Evan C	Low density microspheres and their use as contrast agents for computed tomography
US5824865A (en)	1991-04-08	1998-10-20	Rhone Poulenc Agrochimie	Chimeric plant genes based on upstream regulatory elements of helianthinin
ATE202144T1 (de)	1991-04-09	2001-06-15	Unilever Nv	Pflanzen-promoter involviert in der kontrolle der lipid-biosynthese in samen
WO1992020373A1 (en)	1991-05-14	1992-11-26	Repligen Corporation	Heteroconjugate antibodies for treatment of hiv infection
CA2110169A1 (en)	1991-05-30	1992-12-10	Walter Van Der Eycken	Nematode-responsive plant promoters
US6034298A (en)	1991-08-26	2000-03-07	Prodigene, Inc.	Vaccines expressed in plants
US5612487A (en)	1991-08-26	1997-03-18	Edible Vaccines, Inc.	Anti-viral vaccines expressed in plants
UA48104C2 (uk)	1991-10-04	2002-08-15	Новартіс Аг	Фрагмент днк, який містить послідовність,що кодує інсектицидний протеїн, оптимізовану для кукурудзи,фрагмент днк, який забезпечує направлену бажану для серцевини стебла експресію зв'язаного з нею структурного гена в рослині, фрагмент днк, який забезпечує специфічну для пилку експресію зв`язаного з нею структурного гена в рослині, рекомбінантна молекула днк, спосіб одержання оптимізованої для кукурудзи кодуючої послідовності інсектицидного протеїну, спосіб захисту рослин кукурудзи щонайменше від однієї комахи-шкідника
WO1993008829A1 (en)	1991-11-04	1993-05-13	The Regents Of The University Of California	Compositions that mediate killing of hiv-infected cells
US5968502A (en)	1991-11-05	1999-10-19	Transkaryotic Therapies, Inc.	Protein production and protein delivery
US6270989B1 (en)	1991-11-05	2001-08-07	Transkaryotic Therapies, Inc.	Protein production and delivery
US5641670A (en)	1991-11-05	1997-06-24	Transkaryotic Therapies, Inc.	Protein production and protein delivery
US5824857A (en)	1991-11-08	1998-10-20	Washington University	Plant promoter
TW261517B (de)	1991-11-29	1995-11-01	Mitsubishi Shozi Kk
CA2132323A1 (en)	1992-03-20	1993-09-30	Gunter Strittmatter	Fungus-responsive chimaeric gene
ATE229076T1 (de)	1992-04-02	2002-12-15	Sembiosys Genetics Inc	Cis elemente des ölkörperproteins als regulationische signale
US5712112A (en)	1992-11-04	1998-01-27	National Science Council Of R.O.C.	Gene expression system comprising the promoter region of the alpha-amylase genes
WO1994012015A1 (en)	1992-11-30	1994-06-09	Chua Nam Hai	Expression motifs that confer tissue- and developmental-specific expression in plants
TW402639B (en)	1992-12-03	2000-08-21	Transkaryotic Therapies Inc	Protein production and protein delivery
EP0674708A4 (de)	1992-12-15	1996-07-24	Commw Scient Ind Res Org	Dna moleküle welche für induzierbare pflanzenpromotoren und tomaten adh2 enzyme kodieren.
US5593972A (en)	1993-01-26	1997-01-14	The Wistar Institute	Genetic immunization
DE4313413A1 (de)	1993-04-23	1994-10-27	Basf Ag	3-(Het)aryloxy(thio)-Carbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung
ATE301201T1 (de)	1993-06-07	2005-08-15	Vical Inc	Für die gentherapie verwendbare plasmide
US5814618A (en)	1993-06-14	1998-09-29	Basf Aktiengesellschaft	Methods for regulating gene expression
US5837832A (en)	1993-06-25	1998-11-17	Affymetrix, Inc.	Arrays of nucleic acid probes on biological chips
US5858659A (en)	1995-11-29	1999-01-12	Affymetrix, Inc.	Polymorphism detection
US5691188A (en)	1994-02-14	1997-11-25	American Cyanamid Company	Transformed yeast cells expressing heterologous G-protein coupled receptor
US5834252A (en)	1995-04-18	1998-11-10	Glaxo Group Limited	End-complementary polymerase reaction
US5605793A (en)	1994-02-17	1997-02-25	Affymax Technologies N.V.	Methods for in vitro recombination
US5837458A (en)	1994-02-17	1998-11-17	Maxygen, Inc.	Methods and compositions for cellular and metabolic engineering
US6117679A (en)	1994-02-17	2000-09-12	Maxygen, Inc.	Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5989808A (en)	1994-06-14	1999-11-23	American Cyanamid Company	Identification of compounds affecting specific interaction of peptide binding pairs
US6080560A (en)	1994-07-25	2000-06-27	Monsanto Company	Method for producing antibodies in plant cells
US5646333A (en)	1994-09-02	1997-07-08	Drexel University	Plant promoter useful for directing the expression of foreign proteins to the plant epidermis
CA2200434A1 (en)	1994-09-19	1996-03-28	Jacob Bakker	Gene constructs encoding crop-protecting agents, as well as transformed plants containing and expressing such constructs, and methods of controlling plague organisms and pathogensin crops
US5750399A (en)	1994-11-14	1998-05-12	The Samuel Roberts Noble Foundation, Inc.	Isoflavone reductase promoter
EP0871731A2 (de)	1995-01-17	1998-10-21	Landbouwuniversiteit Wageningen	Antikörper nur bekämpfung von zystennematoden und diese exprimirende transgene pflanzen
GB9502456D0 (en)	1995-02-08	1995-03-29	Univ Warwick	Control of genes in transgenic plants
WO1996028561A1 (en)	1995-03-09	1996-09-19	MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V.	Chimeric genes comprising a fungus-responsive element
JPH11505417A (ja)	1995-05-05	1999-05-21	ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド	ヒトケモカインベータ−８、ケモカインベータ−１、およびマクロファージ炎症性タンパク質−４
US5824872A (en)	1996-02-01	1998-10-20	Miki; Brian	A constitutive promoter from tobacco
CA2149000C (en)	1995-05-09	2007-04-24	Brian Miki	A seed coat-specific cryptic promoter in tobacco
US5545531A (en)	1995-06-07	1996-08-13	Affymax Technologies N.V.	Methods for making a device for concurrently processing multiple biological chip assays
US5856174A (en)	1995-06-29	1999-01-05	Affymetrix, Inc.	Integrated nucleic acid diagnostic device
WO1997010328A2 (en)	1995-07-13	1997-03-20	Ribozyme Pharmaceuticals, Inc.	Compositions and method for modulation of gene expression in plants
US6020169A (en)	1995-07-20	2000-02-01	Washington State University Research Foundation	Production of secreted foreign polypeptides in plant cell culture
GB9516961D0 (en)	1995-08-18	1995-10-18	Zeneca Ltd	Plant gene specifying acetyl coenzyme a carboxylase biotin carboxyl carrier protein and transformed plants containing same
US5792933A (en)	1995-10-04	1998-08-11	Mississippi State University	Fiber-specific protein expression in the cotton plant
EP0853676B1 (de)	1995-10-06	2006-06-21	Bayer BioScience N.V.	Samenstrenung resistenz
US5804694A (en)	1995-11-06	1998-09-08	Prodigene, Inc.	Commercial production of β-glucuronidase in plants
US5783393A (en)	1996-01-29	1998-07-21	Agritope, Inc.	Plant tissue/stage specific promoters for regulated expression of transgenes in plants
ATE319841T1 (de)	1996-06-12	2006-03-15	Japan Tobacco Inc	Verfahren zur expression von fremdgenen und entsprechende vektoren
US5986174A (en)	1996-06-21	1999-11-16	Pioneer Hi-Bred International, Inc.	Maize promoter sequence for leaf- and stalk-preferred gene expression
US5879906A (en)	1996-06-26	1999-03-09	Cambia Biosystems Llc	Glucuronide repressors and uses thereof
US5834236A (en)	1996-06-27	1998-11-10	The Salk Institute For Biological Studies	AATT repeat transcription enhancer element
EP0954581B1 (de)	1996-07-23	2010-07-14	Sapporo Breweries Ltd.	Genexpressionsregulator-dna, expressionskassette, expressionsvektor und transgene pflanze
WO1998003536A1 (en)	1996-07-23	1998-01-29	Novartis Ag	Chemically-inducible arabidopsis pr-1 promoter
US7199233B1 (en)	1996-08-23	2007-04-03	Peter Ruhdal Jensen	Artificial promoter libraries for selected organisms and promoters derived from such libraries
US5981841A (en)	1996-08-30	1999-11-09	Monsanto Company	Early seed 5' regulatory sequence
WO1998008961A2 (en)	1996-08-30	1998-03-05	Olsen Odd Arne	Endosperm and nucellus specific genes, promoters and uses thereof
AU4341997A (en)	1996-09-10	1998-04-02	Regents Of The University Of California, The	Msenod40 promoter compositions and methods of use
AU4503797A (en)	1996-09-27	1998-04-17	Maxygen, Inc.	Methods for optimization of gene therapy by recursive sequence shuffling and selection
CA2268265A1 (en)	1996-09-27	1998-04-02	Maxygen, Inc.	Methods for optimization of gene therapy by recursive sequence shuffling and selection
GB9621383D0 (en)	1996-10-14	1996-12-04	Roslin Inst Edinburgh	Transgene expression
US5856104A (en)	1996-10-28	1999-01-05	Affymetrix, Inc.	Polymorphisms in the glucose-6 phosphate dehydrogenase locus
US5955361A (en)	1996-11-20	1999-09-21	Pioneer Hi-Bred International, Inc.	P gene promoter constructs for floral-tissue preferred gene expression
AU5530198A (en)	1996-12-16	1998-07-15	Zymogenetics Inc.	Compositions and methods for stimulating pancreatic islet cell regeneration
AU743305C (en)	1997-01-17	2006-03-30	Maxygen, Inc.	Evolution of whole cells and organisms by recursive sequence recombination
AU720780B2 (en)	1997-01-20	2000-06-15	Plant Genetic Systems N.V.	Pathogen-induced plant promoters
DK0971946T3 (da)	1997-01-21	2006-10-30	Gen Hospital Corp	Selektion af proteiner ved anvendelse af RNA-protein-fusioner
GB9701425D0 (en)	1997-01-24	1997-03-12	Bioinvent Int Ab	A method for in vitro molecular evolution of protein function
US6066781A (en)	1997-02-13	2000-05-23	Applied Phytologics, Inc.	Production of mature proteins in plants
US5922564A (en)	1997-02-24	1999-07-13	Performance Plants, Inc.	Phosphate-deficiency inducible promoter
US6090800A (en)	1997-05-06	2000-07-18	Imarx Pharmaceutical Corp.	Lipid soluble steroid prodrugs
US6153410A (en)	1997-03-25	2000-11-28	California Institute Of Technology	Recombination of polynucleotide sequences using random or defined primers
US5939541A (en)	1997-03-28	1999-08-17	University Of South Carolina	Method for enhancing expression of a foreign or endogenous gene product in plants
NZ500741A (en)	1997-04-09	2001-06-29	Ministry Of Agriculture And Fo	Inducible plant promoters selected from apple beta-galactosidase (ABG1) or 1-aminocyclopropane-1-carboxylate synthase (ACC synthase)
US7262338B2 (en) *	1998-11-13	2007-08-28	Performance Plants, Inc.	Stress tolerance and delayed senescence in plants
EP1564296A1 (de) *	1997-08-01	2005-08-17	Performance Plants, Inc.	Stress Toleranz und verzögerte Seneszenz in Pfanzen
EP1007712A4 (de)	1997-08-05	2004-06-30	Kimeragen Inc	Verwendung von duplex-oligonukleotiden zur beeinflussung lokaler genetischer veränderungen in pflanzen
US6541621B1 (en)	1997-09-12	2003-04-01	Purdue University Research Foundation	Hypoxia inducible promoter
US6004804A (en)	1998-05-12	1999-12-21	Kimeragen, Inc.	Non-chimeric mutational vectors
US6693185B2 (en)	1998-07-17	2004-02-17	Bayer Bioscience N.V.	Methods and means to modulate programmed cell death in eukaryotic cells
WO2000005391A1 (en)	1998-07-21	2000-02-03	Dow Agrosciences Llc	Antibody-mediated down-regulation of plant proteins
MXPA01001445A (es)	1998-08-11	2002-11-29	Large Scale Biology Corp	Metodo para recuperar proteinas a partir del fluido intersticial de tejidos de plantas.
BR9911681A (pt)	1998-08-12	2001-10-02	Maxygen Inc	Embaralhamento de dna para produzir culturas seletivas para herbicidas
WO2000012734A1 (en)	1998-08-28	2000-03-09	The Regents Of The University Of California	Transposon tagging and gene delivery in small grain cereals
EP1109889A1 (de)	1998-08-31	2001-06-27	Maxygen, Inc.	Transformation, selektion und screening von sequenzdurchmischten polynukleotiden zur entwicklung und optimierung von pflanzenphänotypen.
JP2002532098A (ja)	1998-12-11	2002-10-02	インスティテュート・オブ・モレキュラー・アグロバイオロジー	ユビキチンまたはキュウリ・モザイク・ウイルス被覆タンパク質ペプチドによる高等植物におけるタンパク質産生の増加
AUPP807799A0 (en)	1999-01-08	1999-02-04	University Of Queensland, The	Polynucleotide and method
EP1033405A3 (de) *	1999-02-25	2001-08-01	Ceres Incorporated	DNS-fragmente mit bestimmter Sequenz und die dadurch kodierte Polypeptide

2001
- 2001-08-27 CA CA002420325A patent/CA2420325A1/en not_active Abandoned
- 2001-08-27 AU AU8847801A patent/AU8847801A/xx active Pending
- 2001-08-27 AT AT01968216T patent/ATE497007T1/de not_active IP Right Cessation
- 2001-08-27 CN CNA018174388A patent/CN1564869A/zh active Pending
- 2001-08-27 JP JP2002522296A patent/JP4932125B2/ja not_active Expired - Fee Related
- 2001-08-27 ES ES01968216T patent/ES2361925T3/es not_active Expired - Lifetime
- 2001-08-27 EP EP01968216A patent/EP1349946B1/de not_active Expired - Lifetime
- 2001-08-27 ZA ZA200301579A patent/ZA200301579B/en unknown
- 2001-08-27 BR BR0113512-0A patent/BR0113512A/pt not_active Application Discontinuation
- 2001-08-27 DE DE60143959T patent/DE60143959D1/de not_active Expired - Lifetime
- 2001-08-27 US US10/362,902 patent/US20040219525A1/en not_active Abandoned
- 2001-08-27 EP EP09177897A patent/EP2157183A1/de not_active Withdrawn
- 2001-08-27 AU AU2001288478A patent/AU2001288478B2/en not_active Ceased
- 2001-08-27 WO PCT/US2001/026854 patent/WO2002016625A2/en not_active Ceased
- 2001-08-27 IL IL15459601A patent/IL154596A0/xx unknown
2003
- 2003-02-24 IL IL154596A patent/IL154596A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
WO2002016625A2 (en)	2002-02-28
ES2361925T3 (es)	2011-06-24
AU8847801A (en)	2002-03-04
ATE497007T1 (de)	2011-02-15
WO2002016625A3 (en)	2003-08-07
EP1349946A2 (de)	2003-10-08
IL154596A (en)	2011-07-31
IL154596A0 (en)	2003-09-17
CN1564869A (zh)	2005-01-12
AU2001288478B2 (en)	2006-11-02
BR0113512A (pt)	2005-05-10
US20040219525A1 (en)	2004-11-04
EP2157183A1 (de)	2010-02-24
JP4932125B2 (ja)	2012-05-16
DE60143959D1 (de)	2011-03-10
EP1349946B1 (de)	2011-01-26
JP2004521610A (ja)	2004-07-22
CA2420325A1 (en)	2002-02-28

Publication	Publication Date	Title
EP1339849B1 (de)	2006-10-18	Neuartige, für na+/h+ antiporter kodierende pflanzliche polynukleotide
AU2001288404A1 (en)	2002-05-30	Plant polynucleotides encoding novel Na+/H+ antiporters
Qu et al.	2003	Molecular cloning and functional analysis of a novel type of Bowman-Birk inhibitor gene family in rice
AU2001288478B2 (en)	2006-11-02	Plant polynucleotides encoding prenyl proteases
US9109039B2 (en)	2015-08-18	Plant defense signal peptides
Sun et al.	2013	A Glycine soja ABA-responsive receptor-like cytoplasmic kinase, GsRLCK, positively controls plant tolerance to salt and drought stresses
US20110065191A1 (en)	2011-03-17	Isolated nucleic acids encoding farnesyltransferase polypeptides
AU2001288478A1 (en)	2002-05-30	Plant polynucleotides encoding prenyl proteases
McGee et al.	2003	Rice phospholipase D isoforms show differential cellular location and gene induction
AU2002334300B2 (en)	2008-07-10	Caax prenyl protease nucleic acids and polypeptides and methods of use thereof
US7951991B2 (en)	2011-05-31	Polynucleotides encoding plant prenyl proteases
US6316697B1 (en)	2001-11-13	Constitutive disease resistance(CDR1) gene and methods of use thereof
US20050289669A1 (en)	2005-12-29	TTG3 deficient plants, nucleic acids, polypeptides and methods of use thereof
WO2001053501A2 (en)	2001-07-26	Glutathione-s-transferase nucleic acids and polypeptides and methods of use thereof
WO2004046362A2 (en)	2004-06-03	Hydroxypyruvate reductase promoter elements and methods of use thereof in plants
Liu et al.	2013	XiaoLi Sun, Mingzhe Sun, Xiao Luo, XiaoDong Ding, Wei Ji, Hua Cai, Xi Bai